Table 4

Proportion of patients who may potentially avoid liver biopsy using the simple non-invasive tests to exclude advanced fibrosis

Cut-offPatients avoiding liver biopsy*False negative result
AST/ALT<0.8100/145 (69%)7 (7%)
BARD score<255/145 (38%)3 (5%)
FIB-4 score<1.3090/145 (62%)4 (5%)
NAFLD fibrosis score<−1.45575/145 (52%)6 (8%)
  • * Patients with a value below the cut-off.

  • ALT, alanine aminotransferase; AST, aspartate aminotransferase; NAFLD, non-alcoholic fatty liver disease.